New injection aims to tame autoimmune attacks
NCT ID NCT07408336
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests a new injection called AFN50 in 18 adults with autoimmune diseases like lupus. The main goal is to check safety and see how the body reacts, including changes in immune cells. Participants must have active disease despite standard treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
First Affiliated Hospital of Anhui Medical University
RECRUITINGHefei, Anhui, 230001, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.